For most families raising a neurodivergent child in India, therapy happens one hour a week — if they can get a slot at all. The other 167 hours are up to the parents. Rewin Health, a Chennai-based digital therapeutics company, has spent the last few years building technology to fill exactly that gap. Its new platform, JADHU, launched on 14 October 2026, is what the company describes as India’s first AI-powered daily life-skills platform for differently abled children, teens and adults.
JADHU works in two layers at once. The foundational layer builds core neuro-developmental skills — attention, cognition, communication, motor skills, sensory regulation, visual perception, social participation, daily living and academics — across nine domains. The application layer lets learners rehearse those skills in real-world situations: grocery shopping, travelling on a bus, dining out, handling classroom routines, and more than 40 other everyday scenarios, in a setting where getting it wrong costs nothing.
JADHU’s home practice sessions run on an ordinary smartphone or tablet. (Image: JADHU/Rewin Health)
After an initial assessment, the platform generates a fresh session every morning — two 30-minute blocks a day — drawn from a library of more than 200 therapeutic games, the company says. The AI personalises the difficulty to each learner’s pace, and practice runs on an ordinary smartphone or tablet. The same phone slides into a low-cost JADHU Viewer for a 360-degree environment, while fully immersive sessions on a Meta Quest headset are available at partner clinics, hospitals and schools where a therapist recommends them.
Perhaps the most distinctive piece of engineering is a small Bluetooth wristband — like a fitness tracker — that monitors physiological signals in real time. When it detects rising anxiety, JADHU paces the session down and guides the learner through calming and breathing strategies, fostering independent emotional self-regulation. Parents get a WhatsApp update after every session, a weekly summary of sessions and anxiety trends, a monthly report across all nine skill domains as a shareable PDF, and a six-month before-and-after comparison. Therapists work from a companion app on the same underlying data.
The JADHU VR experience, available at partner clinics on Meta Quest headsets. (Image: JADHU/Rewin Health)
More Read
The platform has been validated in collaboration with eight premier medical institutions, special schools and care organisations, the company says. The launch builds on Rewin Health’s statewide study, “Mapping the Gap: Differently Abled Care in Tamil Nadu 2026” — based on 2,027 respondents and 27 government interviews — which found that 61% of families wait over a year for a diagnosis, 74% face severe cost pressures, 72% lack access to structured therapy, and 83% of parents say what their child learns in therapy does not carry into daily life. The launch event in Chennai was attended by S Madhumathi, Secretary of Tamil Nadu’s Department for the Welfare of Differently Abled Persons.
To mark the launch, Rewin Health announced that 500 differently abled families across Tamil Nadu will receive free access to JADHU, plus support and therapy sessions — a community investment of ₹3 crore funded entirely by the company.
Rewin Health itself is no newcomer to clinical technology. The company — a platform of Rezov Technologies Pvt Ltd, Chennai, founded by Vijay Karunakaran — describes itself as building AI, virtual reality and sensor-based rehabilitation platforms for neurological, orthopaedic, cardiopulmonary, geriatric and differently abled care. Its platforms are used across 55+ clinical centres in India alongside its own network of Rewin Clinics in Tamil Nadu, and its stroke-rehabilitation work across 330+ patients — validated by institutions including the Government Institute of Rehabilitation Medicine, the National Centre for Aging and NIMHANS — forms the clinical backbone JADHU now extends to neurodivergent care.
Therapy gives a family one hour a week. JADHU puts sixty minutes of guided, personalised practice into the home every single day. For the millions of Indian families told to wait — for a diagnosis, for a slot, for a professional with time — that is not a small thing. It is independence, rehearsed until it sticks.
Keep reading: Living Bioreactors: Inside Loopworm, the Bengaluru Startup Turning Silkworms Into Protein Factories · Two Targets, No Escape: Inside the Nucelion–VeGen Bio Alliance Building India’s First Dual-Target CAR-T Cancer Therapy · More Chemicals, Materials & Life Sciences stories
Like stories like this? Add Exceptional Technology as a preferred source on Google to see more of our reporting in your search results and Discover feed.
